<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2015-12-01" updated="2019-12-02">
  <drugbank-id primary="true">DB10790</drugbank-id>
  <name>Bordetella pertussis fimbriae 2/3 antigen</name>
  <description>Bordetella pertussis fimbriae 2/3 antigen is a vaccine for the prophylaxis of the disease caused by Bordetella pertussis which is a a Gram-negative coccobacillus that expresses two serologically distinct fimbriae (Fim2 and Fim3).</description>
  <cas-number/>
  <unii>1O0600285A</unii>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A31172</ref-id>
        <pubmed-id>22956654</pubmed-id>
        <citation>Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR: Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Clin Vaccine Immunol. 2012 Nov;19(11):1776-83. doi: 10.1128/CVI.00355-12. Epub 2012 Sep 5.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Bordetella pertussis fimbriae 2/3 vaccine, inactivated</synonym>
  </synonyms>
  <products>
    <product>
      <name>Adacel TDaP</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-400</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-06-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125111</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adacel TDaP TDaP</name>
      <labeller>Remedy Repack</labeller>
      <ndc-id/>
      <ndc-product-code>52125-848</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-11-14</started-marketing-on>
      <ended-marketing-on>2016-03-29</ended-marketing-on>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125111</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-1079</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-06-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125111</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Daptacel</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-286</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-05-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA103666</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pentacel</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-510</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-06-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125145</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Quadracel</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-562</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125525</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vaxelis</name>
      <labeller>MCM Vaccine Co.</labeller>
      <ndc-id/>
      <ndc-product-code>63361-245</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-12-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125563</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Adacel TDaP TDaP</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Daptacel</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Vaxelis</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) + Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen + Hepatitis B Vaccine (Recombinant) + Poliovirus type 1 antigen (formaldehyde inactivated) + Poliovirus type 2 antigen (formaldehyde inactivated) + Poliovirus type 3 antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Adacel TDaP</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Quadracel</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) + Poliovirus type 1 antigen (formaldehyde inactivated) + Poliovirus type 2 antigen (formaldehyde inactivated) + Poliovirus type 3 antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Pentacel</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) + Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen + Poliovirus type 1 antigen (formaldehyde inactivated) + Poliovirus type 2 antigen (formaldehyde inactivated) + Poliovirus type 3 antigen (formaldehyde inactivated)</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Actively Acquired Immunity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Inactivated Bordetella Pertussis Vaccine</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection, suspension</form>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
    <dosage>
      <form/>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347910900</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>